Author

Nikolaus Ansorge

Observed names: N Ansorge, N. Ansorge, N. Ansorge, Nikolaus Daniel Thomas Ansorge

Observed institutions: University Hospitals of the Ruhr-University of Bochum, Essen University Hospital, Universitätsmedizin Rostock, St. Josef-Hospital, University of Rostock, Ruhr University Bochum

OpenAlex ID: A5012271501

A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations

2003 · Peter Felderbauer, Peter Hoffmann, et al. · BMC Gastroenterology · 95

PDF

Mutations in the calcium-sensing receptor: A new genetic risk factor for chronic pancreatitis?

2005 · P. Felderbauer, W. Klein, et al. · Scandinavian Journal of Gastroenterology · 82

Enhanced fMLP‐stimulated chemotaxis in human neutrophils from individuals carrying the G protein β3 subunit 825 T‐allele

1998 · Sebastian Virchow, Nikolaus Ansorge, et al. · FEBS Letters · 79

The G protein β3 subunit splice variant Gβ3-s causes enhanced chemotaxis of human neutrophils in response to interleukin-8

1999 · S. Virchow, N. Ansorge, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 72

Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro—evidence for a TGF-β-mediated effect

2004 · K Bulut, J.J Meier, et al. · Regulatory Peptides · 52

Ischemia/reperfusion-induced pancreatitis in rats: a new model of complete normothermic in situ ischemia of a pancreatic tail-segment

2001 · R. Obermaier, S. Benz, et al. · Clinical and Experimental Medicine · 32

Vascular endothelial growth factor (VEGF164) ameliorates intestinal epithelial injuryin vitroin IEC-18 and Caco-2 monolayers via induction of TGF-β release from epithelial cells

2006 · K. Bulut, C. Pennartz, et al. · Scandinavian Journal of Gastroenterology · 26

Identification of a Novel Calcium-Sensing Receptor Gene Mutation Causing Familial Hypocalciuric Hypercalcemia by Single-Strand Conformation Polymorphism Analysis

2005 · P. Felderbauer, P. Hoffmann, et al. · Experimental and Clinical Endocrinology & Diabetes · 17

Exogenous and Endogenous Nitric Oxide Donors Improve Post-Ischemic Tissue Oxygenation in Early Pancreatic Ischemia/Reperfusion Injury in the Rat

2004 · R. Obermaier, E. von Dobschuetz, et al. · European Surgical Research · 12

Acquired pure megakaryocytic aplasia: a separate haematological disease entity or a syndrome with multiple causes?

2004 · P. Felderbauer, P. R. Ritter, et al. · European Journal Of Haematology · 11

The CCK-2/gastrin splice variant receptor retaining intron 4 transactivates the COX-2 promoter in vitro

2007 · He Huang, Nikolaus Ansorge, et al. · Regulatory Peptides · 7

An upstream CRE-E-box element is essential for gastrin-dependent activation of the cyclooxygenase-2 gene in human colon cancer cells

2007 · Nikolaus Ansorge, Stefan Jüttner, et al. · Regulatory Peptides · 6

Mitoxantron-assoziierte akute Leukämie bei Multipler Sklerose

2010 · C. Meyer, N. Ansorge, et al. · Der Nervenarzt · 2

1624P Predictive factors for treatment success of second-line Nal-IRI/5-FU/FA in patients with metastatic pancreatic ductal adenocarcinoma (PDAC) (AIO-PAK-0216)

2023 · M.P. Lutz, N. Ansorge, et al. · Annals of Oncology · 1

PDF

Pancreatitis in Primary Hyperparathyroidism-related Hypercalcaemia Is Strongly Associated With Mutations in the Spink1 Trypsin Inhibitor (n34s) and the Cftr Gene

2006 · P. Felderbauer, E. Karakas, et al. · Pancreas · 1

A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in individuals with heterozygous SPINKI mutations

2003 · Peter Felderbauer, Nikolaus Ansorge, et al. · Gastroenterology · 1

PDF

Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216)

2025 · Manfred P. Lutz, Nikolaus Ansorge, et al. · British Journal of Cancer

PDF

A PBMC and machine learning based biomarker signature to predict second line chemotherapy success in advanced PDAC: Translational data of the PREDICT trial—A prospective, multicenter, trial of the AIO Pancreatic Cancer Group (AIO-PAK-0216).

2025 · Anton Lahusen, Manfred P. Lutz, et al. · Journal of Clinical Oncology

PDF

Second-line therapy with Nal-IRI/5-FU/FA after failure of gemcitabine/nab-paclitaxel in advanced pancreatic cancer (PC): Predictive role of 1st-line therapy (PREDICT) and impact of quality of life (QoL).

2025 · Meinolf Karthaus, Jerome Schwingel, et al. · Journal of Clinical Oncology

PDF

386P Exploratory biomarker analysis based on the PREDICT trial (AIO-PAK-0216) for response prediction to second-line nal-IRI/5-FU/FA chemotherapy (CTX) in metastatic PDAC patients (mPDAC Pts)

2024 · A. Lahusen, M.P. Lutz, et al. · Annals of Oncology

Prediction of early treatment failure of second-line nal-iri/5-FU/FA in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216).

2023 · Meinolf Karthaus, Nikolaus Ansorge, et al. · Journal of Clinical Oncology

PDF

Glukagon-like peptide 2 induziert Migration in intestinalen Dünndarm Epithelzellen über eine Freisetzung von TGF-β

2015 · K Bulut, N Ansorge, et al. · Zeitschrift für Gastroenterologie

Eine neu identifizierte Mutation des Calcium-Sensing Rezeptors (518T>C) ist assoziiert mit chronischer Pankreatitis in einer Familie mit heterozygoten SPINK1 (N34S) Mutanten

2015 · P Felderbauer, P Hoffmann, et al. · Zeitschrift für Gastroenterologie

Adjuvante Therapie des Kolon- und Rektumkarzinoms

2008 · N. Ansorge, W. Schmidt, et al. · Die Gastroenterologie

Differentielle Wirkung des GLP-2 am Dünn- und Dickdarm über eine VEGF-Freisetzung aus subepithelialen Myofibroblasten

2006 · K Bulut, C Pennartz, et al. · Zeitschrift für Gastroenterologie

Works count: 31

Citation count: 496

H-index: 10

I10-index: 10